Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 1, Issue 4, pp. 235-244
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 31, 2013
- Revision received August 2, 2013
- Accepted August 5, 2013
- Published first August 12, 2013.
Article Versions
- Previous version (August 12, 2013 - 05:43).
- Previous version (September 5, 2013 - 07:28).
- You are viewing the most recent version of this article.
Copyright & Usage
©2013 American Association for Cancer Research.
Author Information
- Shigehisa Kitano1,
- Takemasa Tsuji6,
- Caillian Liu1,3,
- Daniel Hirschhorn-Cymerman3,
- Chrisann Kyi4,
- Zhenyu Mu1,
- James P. Allison7,
- Sacha Gnjatic5,
- Jianda D. Yuan1, and
- Jedd D. Wolchok1,2,3,4
- Authors' Affiliations: 1Ludwig Center for Cancer Immunotherapy, Immunology Program, 2Department of Medicine, 3Swim Across America Laboratory, and Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center; 4Weill Cornell Medical College of Cornell University; and 5Mount Sinai Icahn School of Medicine, Tisch Cancer Institute, New York; and 6Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York; 7Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
- Corresponding Author:
Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065. Phone: 646-888-2395; Fax: 646-422-0453; E-mail: wolchokj{at}mskcc.org
October 2013
Volume 1, Issue 4
Volume 1, Issue 4
Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients
Jump to section
Advertisement